The FDA’s premarket review process is supposed to ensure that new tobacco products stay off the market until they receive affirmative marketing orders from the FDA. Yet that is not how the process has unfolded, and millions of products on the market have not gone through premarket review. In fact, only a few tobacco products have ever received federal authorization to be sold. This webinar will provide a brief overview of the premarket review process, discuss the marketing authorizations that the FDA recently issued, and provide insight into what we expect to happen over the coming months. Presenters will also describe local efforts to prevent the sale of unauthorized products and identify potential policy solutions in California moving forward.
Kyra Hill and Neil Sircar, Public Health Law Center